Literature DB >> 23064545

Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre study.

Hojjat Ahmadzadehfar1, Carsten Meyer, Samer Ezziddin, Amir Sabet, Anja Hoff-Meyer, Marianne Muckle, Timur Logvinski, Hans Heinz Schild, Hans Jürgen Biersack, Kai Wilhelm.   

Abstract

PURPOSE: Lobar radioembolization (RE) of the liver can result in reduction in volume of the ipsilateral lobe as well as hypertrophy of the contralateral lobe. Theoretically, hypertrophy of the contralateral liver lobe after RE could increase the chance of a successful liver resection, especially in patients with limited liver function reserve. The aim of this preliminary study was to evaluate the early effects of RE with resin microspheres on the volumes of the liver lobes and spleen.
METHODS: We retrospectively investigated 24 patients (12 women, 44-78 years old) with different types of cancer and liver-dominant metastatic disease who had undergone RE of the liver with resin microspheres. Changes in the volumes of the liver lobes and spleen were quantified by CT before and about 4 to 8 weeks after treatment.
RESULTS: Of the 24 patients, 17 suffered from metastases in both liver lobes (group A) and 7 had metastases only in the right liver lobe (group B). The patients in the group A underwent sequential treatment starting with the right liver lobe. The median administered dose was 1.75 GBq. RE was associated with a median increase in volume of the left liver lobe of 34 % (P < 0.001) and a median decrease in volume of the right liver lobe of 11 % (P = 0.03). The volume of the spleen showed a median increase of 17 % (P = 0.01). Separate analysis of the two groups showed a median increases in volume of the left liver lobe of 30 % (P = 0.001) in group A and 70 % (P = 0.01) in group B. There was no correlation between the injected dose and the volume alteration (r = 0.1-0.3).
CONCLUSION: RE of the right liver lobe with resin microspheres caused a significant increase in the volume of the left liver lobe. This may allow liver resection in patients with metastases in the right liver lobe and a small left liver lobe.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23064545     DOI: 10.1007/s00259-012-2253-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  34 in total

Review 1.  Resection of liver metastases from breast cancer: towards a management guideline.

Authors:  Mohammad Howlader; Nigel Heaton; Mohamed Rela
Journal:  Int J Surg       Date:  2011-01-31       Impact factor: 6.071

2.  Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.

Authors:  Riad Salem; Robert J Lewandowski; Laura Kulik; Edward Wang; Ahsun Riaz; Robert K Ryu; Kent T Sato; Ramona Gupta; Paul Nikolaidis; Frank H Miller; Vahid Yaghmai; Saad M Ibrahim; Seanthan Senthilnathan; Talia Baker; Vanessa L Gates; Bassel Atassi; Steven Newman; Khairuddin Memon; Richard Chen; Robert L Vogelzang; Albert A Nemcek; Scott A Resnick; Howard B Chrisman; James Carr; Reed A Omary; Michael Abecassis; Al B Benson; Mary F Mulcahy
Journal:  Gastroenterology       Date:  2010-10-30       Impact factor: 22.682

3.  Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

Authors:  Bruno Sangro; Livio Carpanese; Roberto Cianni; Rita Golfieri; Daniele Gasparini; Samer Ezziddin; Philipp M Paprottka; Francesco Fiore; Mark Van Buskirk; Jose Ignacio Bilbao; Giuseppe Maria Ettorre; Rita Salvatori; Emanuela Giampalma; Onelio Geatti; Kai Wilhelm; Ralf Thorsten Hoffmann; Francesco Izzo; Mercedes Iñarrairaegui; Carlo Ludovico Maini; Carlo Urigo; Alberta Cappelli; Alessandro Vit; Hojjat Ahmadzadehfar; Tobias Franz Jakobs; Secondo Lastoria
Journal:  Hepatology       Date:  2011-06-30       Impact factor: 17.425

4.  Hepatic toxicity after radioembolization of the liver using (90)Y-microspheres: sequential lobar versus whole liver approach.

Authors:  Ricarda Seidensticker; Max Seidensticker; Robert Damm; Konrad Mohnike; Kerstin Schütte; Peter Malfertheiner; Mark Van Buskirk; Maciej Pech; Holger Amthauer; Jens Ricke
Journal:  Cardiovasc Intervent Radiol       Date:  2011-10-26       Impact factor: 2.740

5.  Trends in long-term survival following liver resection for hepatic colorectal metastases.

Authors:  Michael A Choti; James V Sitzmann; Marcelo F Tiburi; Wuthi Sumetchotimetha; Ram Rangsin; Richard D Schulick; Keith D Lillemoe; Charles J Yeo; John L Cameron
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

Review 6.  Radioembolization of liver tumors with yttrium-90 microspheres.

Authors:  Hojjat Ahmadzadehfar; Hans-Jürgen Biersack; Samer Ezziddin
Journal:  Semin Nucl Med       Date:  2010-03       Impact factor: 4.446

7.  Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy.

Authors:  I K Beal; S Anthony; A Papadopoulou; R Hutchins; G Fusai; R Begent; N Davies; J Tibballs; B Davidson
Journal:  Br J Radiol       Date:  2006-06       Impact factor: 3.039

Review 8.  From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Authors:  Richard L Wahl; Heather Jacene; Yvette Kasamon; Martin A Lodge
Journal:  J Nucl Med       Date:  2009-05       Impact factor: 10.057

9.  Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases.

Authors:  Daria Zorzi; Yun Shin Chun; David C Madoff; Eddie K Abdalla; Jean-Nicolas Vauthey
Journal:  Ann Surg Oncol       Date:  2008-07-18       Impact factor: 5.344

10.  Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases.

Authors:  Anne M Covey; Karen T Brown; William R Jarnagin; Lynn A Brody; Lawrence Schwartz; Scott Tuorto; Constantinos T Sofocleous; Michael D'Angelica; George I Getrajdman; Ronald DeMatteo; Nancy E Kemeny; Yuman Fong
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

View more
  15 in total

Review 1.  Local Arterial Therapies in the Management of Unresectable Hepatocellular Carcinoma.

Authors:  Samdeep K Mouli; Laura W Goff
Journal:  Curr Treat Options Oncol       Date:  2017-10-27

Review 2.  Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know.

Authors:  Alexander Villalobos; Mohamed M Soliman; Bill S Majdalany; David M Schuster; James Galt; Zachary L Bercu; Nima Kokabi
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

Review 3.  [Contralateral hepatic hypertrophy following unilateral yttrium-90 radioembolization : Implications for liver surgery].

Authors:  B Garlipp; M Seidensticker; D Jechorek; H Ptok; C J Bruns; J Ricke
Journal:  Chirurg       Date:  2016-05       Impact factor: 0.955

Review 4.  Contra-lateral liver lobe hypertrophy after unilobar Y90 radioembolization: an alternative to portal vein embolization?

Authors:  Jin-Yao Teo; Brian K P Goh
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

Review 5.  Radiation Lobectomy: An Overview of Concept and Applications, Technical Considerations, Outcomes.

Authors:  Pouya Entezari; Ahmed Gabr; Kristie Kennedy; Riad Salem; Robert J Lewandowski
Journal:  Semin Intervent Radiol       Date:  2021-10-07       Impact factor: 1.780

Review 6.  A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90.

Authors:  Jin-Yao Teo; John C Allen; David C Ng; Su-Pin Choo; David W M Tai; Jason P E Chang; Foong-Khoon Cheah; Pierce K H Chow; Brian K P Goh
Journal:  HPB (Oxford)       Date:  2015-12-11       Impact factor: 3.647

Review 7.  Transarterial Chemoembolization and Radioembolization across Barcelona Clinic Liver Cancer Stages.

Authors:  Joseph Titano; Amir Noor; Edward Kim
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

8.  Same-day 90Y radioembolization: implementing a new treatment paradigm.

Authors:  Ahmed Gabr; Joseph Ralph Kallini; Vanessa L Gates; Ryan Hickey; Laura Kulik; Kush Desai; Bartley Thornburg; Karen Marshall; Krystina Salzig; Melissa Williams; Carlene Del Castillo; Daniel Ganger; Elias Hohlastos; Talia Baker; Robert J Lewandowski; Riad Salem
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-17       Impact factor: 9.236

Review 9.  Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.

Authors:  Andrew Kennedy; Daniel B Brown; Jonas Feilchenfeldt; John Marshall; Harpreet Wasan; Marwan Fakih; Peter Gibbs; Alexander Knuth; Bruno Sangro; Michael C Soulen; Gianfranco Pittari; Ricky A Sharma
Journal:  J Gastrointest Oncol       Date:  2017-12

Review 10.  Selective Internal Radiation Therapy (SIRT) as Conversion Therapy for Unresectable Primary Liver Malignancies.

Authors:  Alessandro Cucchetti; Alberta Cappelli; Giorgio Ercolani; Cristina Mosconi; Matteo Cescon; Rita Golfieri; Antonio Daniele Pinna
Journal:  Liver Cancer       Date:  2016-09-14       Impact factor: 11.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.